Related Experiment Video
Updated: Jun 28, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
Introducing sense into nonsense in treatments of human genetic diseases
1Department of Genetics, The Life Sciences Institute, Givat Ram Campus, The Hebrew University, Jerusalem 91904, Israel.
Abstract:
Approximately one-third of alleles causing genetic diseases carry premature termination codons (PTCs), which lead to the production of truncated proteins. The past decade has seen considerable interest in therapeutic approaches aimed at readthrough of in-frame PTCs to enable synthesis of full-length proteins. However, attempts to readthrough PTCs in many diseases resulted in variable effects. Here, we focus on the efforts of such therapeutic approaches in cystic fibrosis and Duchenne muscular dystrophy and discuss the factors contributing to successful readthrough and how the nonsense-mediated mRNA decay (NMD) pathway regulates this response. A deeper understanding of the molecular basis for variable response to readthrough of PTCs is necessary so that appropriate therapies can be developed to treat many human genetic diseases caused by PTCs.
Insights
Therapeutic readthrough of premature termination codons (PTCs) aims to restore full-length proteins for genetic diseases. Variable effects highlight the need to understand factors like nonsense-mediated mRNA decay (NMD) for better therapies.
Area of Science:
- Genetics
- Molecular Biology
- Pharmacology
Background:
- Genetic diseases often result from premature termination codons (PTCs) leading to truncated, non-functional proteins.
- Approximately one-third of disease-causing alleles feature PTCs, presenting a significant therapeutic target.
- Readthrough strategies aim to bypass PTCs, enabling the synthesis of full-length proteins.
Purpose of the Study:
- To investigate therapeutic readthrough approaches for genetic diseases caused by PTCs.
- To analyze factors influencing variable readthrough efficacy in conditions like cystic fibrosis and Duchenne muscular dystrophy.
- To explore the role of nonsense-mediated mRNA decay (NMD) in regulating PTC readthrough responses.
Main Methods:
- Review of existing therapeutic strategies for PTC readthrough.
- Analysis of case studies focusing on cystic fibrosis and Duchenne muscular dystrophy.
- Discussion of molecular mechanisms, including NMD, affecting readthrough outcomes.
Main Results:
- Therapeutic readthrough of PTCs shows promise but exhibits variable efficacy across different diseases and patients.
- Factors influencing readthrough success include PTC context and the activity of cellular pathways like NMD.
- Nonsense-mediated mRNA decay (NMD) plays a critical role in determining the cellular response to PTCs.
Conclusions:
- A deeper understanding of the molecular basis for variable readthrough responses is crucial.
- Targeting factors that modulate readthrough and NMD could lead to more effective therapies for PTC-associated genetic disorders.
- Further research is needed to optimize readthrough therapies for widespread clinical application.
Related Concept Videos
Genetic Lingo
Incomplete Dominance
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

